Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Daniel, Arumi"'
Autor:
Maryam Akbari, Sattar Mirzakuchaki, Daniel Arumi, Salvador Manich, Alvaro Gomez-Pau, Francesca Campabadal, Mireia Bargallo Gonzalez, Rosa Rodriguez-Montanes
Publikováno v:
IEEE Access, Vol 11, Pp 66682-66693 (2023)
Hardware-based security primitives like True Random Number Generators (TRNG) have become a crucial part in protecting data over communication channels. With the growth of internet and cloud storage, TRNGs are required in numerous cryptographic operat
Externí odkaz:
https://doaj.org/article/e68dfd085a36443d89b4b8cde2add0a6
Autor:
Ana Martín-Santiago, MD, Susana Puig, MD PhD, Daniel Arumi, MD PhD, Francisco Jose Rebollo Laserna, MD
Publikováno v:
Current Therapeutic Research, Vol 96, Iss , Pp 100679- (2022)
ABSTRACT: Objective: Evaluate the safety profile and tolerability of topical phosphodiesterase 4 (PDE4) inhibitors versus vehicle as treatment for atopic dermatitis in published studies. Methods: A search was performed in Medline/PubMed, Web of Scien
Externí odkaz:
https://doaj.org/article/c1f70b21120743c3a995cfe90298da6e
Autor:
Fernández, Carmen Suárez, Sales, Juan Cosín, Sánchez, Manuel Anguita, Cabrales, Carlos Arias, Sánchez, Luisa Martínez, Torredemer, Daniel Arumí, de Cabo, Susana Fernández
Publikováno v:
In Revista clinica espanola November 2023 223 Supplement 2:S925-S927
Autor:
Andrés Muñoz, Enrique Gallardo, Giancarlo Agnelli, Carlos Crespo, Monica Forghani, Daniel Arumi, Susana Fernández de Cabo, Javier Soto
Publikováno v:
Journal of medical economics. 25(1)
Recent studies have compared the efficacy and safety of direct-acting oral anticoagulants (DOAC) and low-molecular-weight heparin (LMWH) for cancer-associated venous thromboembolism (VTE). However, there is no available cost-effectiveness analysis co
Autor:
Binbin Yang, Daniel Arumi, Salvador Manich, Alvaro Gomez-Pau, Rosa Rodriguez-Montanes, Juan Bautista Roldan, Mireia Bargallo Gonzalez, Francesca Campabadal, Liang Fang
Publikováno v:
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Universitat Politècnica de Catalunya (UPC)
© 2021 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes,creating new c
Autor:
Eduardo Martínez, Agulló, José, L., Ruiz, Cerdá, Luis Gómez, Pérez, Miguel Ramírez, Backhaus, Francisco Delgado, Oliva, Pablo, Rebollo, Diego González-Segura, Alsina, Daniel, Arumi, de Estudio Cooperativo, Grupo
Publikováno v:
In Actas Urologicas Espanolas 2009 33(2):159-166
Autor:
Andrés J. Muñoz Martín, Sofía Huerga Domínguez, Juan Carlos Souto, Jacobo Rogado Revuelta, Antonio Sanchez, Andres Garcia-Palomo, Jorge Aparicio, Cristina Aguayo, David Gutierrez Abad, Laura Ortega, Maria Carmen Viñuela-Benéitez, Victor Fanjul, David Casadevall, Daniel Arumi, Miguel Ángel Hernández-Presa
Publikováno v:
Journal of Clinical Oncology. 40:e18742-e18742
e18742 Background: The clinical predictors of venous thromboembolism (VTE) recurrence in patients with cancer are not well known. Our objective was to develop a predictive model for risk of VTE recurrence in anticoagulant-treated cancer patients with
Autor:
Andrés J. Muñoz Martín, María Luisa Palacios, Juan Carlos Souto, Berta Obispo, Jorge Aparicio, Andres Garcia-Palomo, Antonio Sanchez, Cristina Aguayo, David Gutierrez Abad, Maria Carmen Viñuela-Benéitez, Diego Benavent, Miren Taberna, Daniel Arumi, Miguel Ángel Hernández-Presa
Publikováno v:
Journal of Clinical Oncology. 40:e18744-e18744
e18744 Background: Evidence regarding the clinical predictors of bleeding risk in patients with cancer and venous thromboembolism (VTE) is lacking. Our aim was to develop a predictive model to assess the risk of major bleeding (MB) in anticoagulant-t
Autor:
Howard B. Goldman, Tekeya Kitta, Daniel Arumi, Steven A. Kaplan, Matthias Oelke, David Russell, Fady Ntanios, Erin Mangan, Martin Carlsson
Publikováno v:
International Urogynecology Journal. 30:239-244
We sought to determine whether baseline characteristics predict which overactive bladder (OAB) patients benefit from fesoterodine 8 mg versus 4 mg. In double-blind, placebo-controlled, flexible-dose trials, baseline characteristics of OAB patients wi
Autor:
Javier Soto, Enrique Gallardo Diaz, Susana Fernandez, Roma Masana Domenech, Daniel Arumi, Andres J. Muñoz Martín, Carlos Crespo
Publikováno v:
Journal of Clinical Oncology. 39:e18845-e18845
e18845 Background: Venous thromboembolism (VTE) causes substantial morbidity and mortality in patients with cancer. The guidelines for the treatment of VTE in cancer patients recommend low molecular weight heparins (LMWH) and direct oral anticoagulan